[Federal Register Volume 60, Number 75 (Wednesday, April 19, 1995)]
[Notices]
[Page 19611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9638]



-----------------------------------------------------------------------


NUCLEAR REGULATORY COMMISSION

Advisory Committee on Medical Uses of Isotopes: Meeting Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene its next 
regular meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on May 11 and 12, 1995. Topics of discussion will 
include: (1) Brachytherapy issues; (2) Guidance documents for the final 
Radiopharmacy Rule; (3) Prostate implant procedures; (4) National 
Program Review II; (5) Training and experience of authorized users to 
allow exemptions to Subpart J; (6) Dose ranges in written directives; 
(7) Petition to review the final Radiopharmacy Rule; (8) Information 
from NIST on Sr-90 calibration errors for eye applicators; (9) 
Revisions to Regulatory Guide 10.8; (10) Status of implementation of 
the Quality Management rule; (11) Update on the study of the medical 
use program by the National Academy of Science; (12) Summary of 
``Business Process Reengineering;'' (13) Update on rulemakings: 
``Medical Administration of Radiation and Radioactive Materials,'' 
``Release of Patients Containing Radiopharmaceuticals or Permanent 
Implants,'' and ``Administration of Byproduct Material or Radiation 
from Byproduct Material to Patients who may be Pregnant or Nursing.''

DATES: The meeting will begin at 8 a.m. on May 11 and 12, 1995.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION CONTACT:
Josephine M. Piccone, Ph.D., U.S. Nuclear Regulatory Commission, Office 
of Nuclear Material Safety and Safeguards, MS T8F5, Washington, DC 
20555, Telephone (301) 415-7270. For administrative information, 
contact Torre Taylor, (301) 415-7900.

Conduct of the Meeting

    Barry Siegel, M.D., will chair the meeting. Dr. Siegel will conduct 
the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Josephine M. Piccone (address listed above). 
Comments must be received by May 3, 1995, to ensure consideration at 
the meeting. The transcript of the meeting will be kept open until May 
19, 1995, for inclusion of written comments.
    2. Persons who wish to make oral statements should inform Dr. 
Piccone in writing, by May 3, 1995. Statements must pertain to the 
topics on the agenda for the meeting. The Chairman will rule on 
requests to make oral statements. Members of the public will be 
permitted to make oral statements if time permits. Permission to make 
oral statements will be based on the order in which requests are 
received. In general, oral statements will be limited to approximately 
5 minutes. Oral statements must be supplemented by detailed written 
statements for the record. Rulings on who may speak, the order of 
presentation, and time allotments may be obtained by calling Dr. 
Piccone, (301) 415-7270, between 8 a.m. and 4 p.m., EST, on May 9, 
1995.
    3. At the meeting, questions from attendees other than committee 
members, NRC consultants, and NRC staff will be permitted at the 
discretion of the Chairman.
    4. The transcript, minutes of the meeting, and written comments 
will be available for inspection, and copying, for a fee, at the NRC 
Public Document Room, 2120 L Street NW, Lower Level, Washington, DC 
20555 (202) 634-3273, on or about May 26, 1995.
    5. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, Code of Federal Regulations, Part 7.

    Dated: April 13, 1995.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 95-9638 Filed 4-18-95; 8:45 am]
BILLING CODE 7590-01-M